glp 1 agonist companies Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Receptor Agonist Market Forecast

doi: 10.2165/11592810-000000000-00000 138 SandersDM

[DOI] [PubMed] [Google Scholar] 73.Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E

The carriers of the loss-of-function GIP receptor variants, R190Q and E288G, display higher blood pressure and an increased tendency toward hypertension (99) but a comprehensive study of larger number of loss-of-function GIP receptor variants did not reveal similar effects on cardiovascular traits (39)

Their heart failure symptoms and physical limitations are due to impaired filling and relaxation of the left ventricle

Moreover, combination treatments like tirzepatide, which pairs GLP-1 analog with glucose-dependent insulinotropic polypeptide, are emerging and predicted to grow

For someone exploring entry-level options, it might seem like a simple place to start